NIH to bank genome-wide association data

As of January 25, 2008, researchers conducting genome-wide association studies with NIH funding will be required to submit their data, stripped of information that could identify individual study participants, to the a linkurl:central repository;http://www.genome.gov/Pages/About/OD/OPG/GWASFR-082807.pdf at the National Library of Medicine. The database will allow researchers not connected with an original study to mine another lab?s data in search of further gene associations. linkurl:Plans;ht

Written byAlla Katsnelson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
As of January 25, 2008, researchers conducting genome-wide association studies with NIH funding will be required to submit their data, stripped of information that could identify individual study participants, to the a linkurl:central repository;http://www.genome.gov/Pages/About/OD/OPG/GWASFR-082807.pdf at the National Library of Medicine. The database will allow researchers not connected with an original study to mine another lab?s data in search of further gene associations. linkurl:Plans;http://www.the-scientist.com/news/display/25033/ for such a database were announced last year ? researchers and patient advocacy groups supported the idea, but raised concerns about issues such as participant privacy and the effect on researchers? ability to publish or derive patents from the data. The final rules for submission encourage researchers and institutions to look into obtaining a special dispensation for confidentiality in cases where particularly sensitive data may be obtained for non-legal purposes (like law enforcement agencies or insurance companies). They also promise to provide guidance to ORBs in developing informed consent for study participants, which will necessarily become more complicated. And while the original draft plan stipulated a nine-month exclusivity period during which secondary researchers cannot publish based on the work, that period has been extended to 12 months in the final version. But with genome-wide studies getting published at an ever-increasing rate, complications around such issues are only likely to increase.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies